| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8645547 | Gene | 2018 | 21 Pages |
Abstract
MiR-93-5p is up-regulated in NSCLC and plays an oncogenic role by inhibiting PTEN and RB1, suggesting miR-93-5p may be a novel prognostic indicator and a therapeutic target in NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Wei Yang, Jinquan Bai, Dayong Liu, Shuwei Wang, Nan Zhao, Richeng Che, Haiyan Zhang,